Skip to main content
Equibles

Stone House Investment Management, LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1696497 TUNKHANNOCK, PA
Back to LNTH Full portfolio

Position in LNTH

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$4,992
+$1,883 QoQ
Shares Held
45
+9.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#419
of 467 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Stone House Investment Management, LLC holds $90,921 across 20 Drug Manufacturers - Specialty & Generic names. LNTH ranks #5 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLAS
Glass House Brands Inc.
 2,500 $32,500
2 KNSA
Kiniksa Pharmaceuticals International, plc
 188 $12,022
3 TAK
Takeda Pharmaceutical Co Ltd
 457 $7,325
4 RDY
Dr Reddys Laboratories Ltd
 452 $6,549
5 LNTH
Lantheus Holdings, Inc.
This page 		45 $4,992
6 HIMS
Hims & Hers Health, Inc.
 135 $4,680
7 AQST
Aquestive Therapeutics, Inc.
 1,044 $4,343
8 HLN
Haleon plc
 450 $4,198

All Filings in LNTH

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,992 45
2026-03-31 $3,109 41